Top compounds associated with response to RAP2C


Feature Type Standardized
Nominal ANOVA
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.077 0.02
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA FK866 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA BRD8899 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.09 0.02
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA paclitaxel GDSC1000 pan-cancer AAC 0.13 0.02
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.072 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.02
Download CSV